TP53 and pancreatic intraductal papillary-mucinous neoplasm: Specific variations in the TP53, GNAS, and SMAD4 genes have emerged as markers of invasive cancer and high-grade dysplasia or for distinguishing adenocarcinoma from IPMN [19,20,21,22].